Reports

Industry Research Reports

Global Specialty Enzymes Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Specialty Enzymes Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-10-26

Pages: 167 Pages

Report ld: 5285507

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Specialty Enzymes Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

7.5%

marketSize

Market Size,2031

USD 1,418

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 919 million
Market Forecast in 2031(Value)
US$ 1,418 million
CAGR
7.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Specialty Enzymes market is projected to grow from US$ 861 million in 2024 to US$ 1418 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Enzymes, also called biocatalysts, are naturally occurring or synthetic proteins that accelerate or decelerate the rate of biochemical reactions, without undergoing change themselves. They have crucial applications in many industries, including food, feed, detergent, laundry, tanning, textiles, pharmaceuticals, cosmetics, and fine-chemicals. The global enzyme industry is segmented into industrial enzymes and specialty enzymes.

During 2017, the pharmaceutical applications segment accounted for the major shares and dominated this market. Factors such its help in ease of digestion will contribute to the growth of this industry segment in the coming years.

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Specialty Enzymes market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • Novozymes
  • Dupont
  • DSM
  • BASF
  • AB Enzymes
  • CHR.Hansen
  • Soufflet Group
  • Longda Bio-products
  • Biocatalysts
  • ORBA
  • Biovet

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Protease
  • Carbohydrases
  • Polymerases and Nucleases
  • Lipase
  • Others

Segment by Application

  • Pharmaceutical Applications
  • Biotechnology and R&D Application
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the Specialty Enzymes study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

marn_i1

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

marn_i1

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

marn_i1

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

marn_i1

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

marn_i1

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

marn_i1

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

marn_i1

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

marn_i1

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.

marn_i1

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

marn_i1

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to Specialty Enzymes: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Specialty Enzymes Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Protease

1.2.3 Carbohydrases

1.2.4 Polymerases and Nucleases

1.2.5 Lipase

1.2.6 Others

1.3 Market Segmentation by Application

1.3.1 Global Specialty Enzymes Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Applications

1.3.3 Biotechnology and R&D Application

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global Specialty Enzymes Revenue Estimates and Forecasts 2020-2031

2.2 Global Specialty Enzymes Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Specialty Enzymes Sales Estimates and Forecasts 2020-2031

2.4 Global Specialty Enzymes Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

muLu

3 Global Production Analysis

3.1 Global Specialty Enzymes Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

muLu

4 Competition by Manufacturers

4.1 Global Specialty Enzymes Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Specialty Enzymes Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Protease Market Size by Manufacturers

4.5.2 Carbohydrases Market Size by Manufacturers

4.5.3 Polymerases and Nucleases Market Size by Manufacturers

4.5.4 Lipase Market Size by Manufacturers

4.5.5 Others Market Size by Manufacturers

4.6 Global Specialty Enzymes Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

muLu

5 Global Product Segmentation Analysis

5.1 Global Specialty Enzymes Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Specialty Enzymes Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

muLu

6 Global Downstream Application Analysis

6.1 Global Specialty Enzymes Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Specialty Enzymes Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

muLu

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Specialty Enzymes Sales and Revenue by Type (2020-2031)

7.4 North America Specialty Enzymes Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Specialty Enzymes Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

muLu

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Specialty Enzymes Sales and Revenue by Type (2020-2031)

8.4 Europe Specialty Enzymes Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Specialty Enzymes Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

muLu

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Specialty Enzymes Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Specialty Enzymes Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Specialty Enzymes Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

muLu

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Specialty Enzymes Sales and Revenue by Type (2020-2031)

10.4 Central and South America Specialty Enzymes Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Specialty Enzymes Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

muLu

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Specialty Enzymes Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Specialty Enzymes Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Specialty Enzymes Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

muLu

12 Corporate Profile

12.1 Novozymes

12.1.1 Novozymes Corporation Information

12.1.2 Novozymes Business Overview

12.1.3 Novozymes Specialty Enzymes Product Models, Descriptions and Specifications

12.1.4 Novozymes Specialty Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Novozymes Specialty Enzymes Sales by Product in 2024

12.1.6 Novozymes Specialty Enzymes Sales by Application in 2024

12.1.7 Novozymes Specialty Enzymes Sales by Geographic Area in 2024

12.1.8 Novozymes Specialty Enzymes SWOT Analysis

12.1.9 Novozymes Recent Developments

12.2 Dupont

12.2.1 Dupont Corporation Information

12.2.2 Dupont Business Overview

12.2.3 Dupont Specialty Enzymes Product Models, Descriptions and Specifications

12.2.4 Dupont Specialty Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Dupont Specialty Enzymes Sales by Product in 2024

12.2.6 Dupont Specialty Enzymes Sales by Application in 2024

12.2.7 Dupont Specialty Enzymes Sales by Geographic Area in 2024

12.2.8 Dupont Specialty Enzymes SWOT Analysis

12.2.9 Dupont Recent Developments

12.3 DSM

12.3.1 DSM Corporation Information

12.3.2 DSM Business Overview

12.3.3 DSM Specialty Enzymes Product Models, Descriptions and Specifications

12.3.4 DSM Specialty Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 DSM Specialty Enzymes Sales by Product in 2024

12.3.6 DSM Specialty Enzymes Sales by Application in 2024

12.3.7 DSM Specialty Enzymes Sales by Geographic Area in 2024

12.3.8 DSM Specialty Enzymes SWOT Analysis

12.3.9 DSM Recent Developments

12.4 BASF

12.4.1 BASF Corporation Information

12.4.2 BASF Business Overview

12.4.3 BASF Specialty Enzymes Product Models, Descriptions and Specifications

12.4.4 BASF Specialty Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 BASF Specialty Enzymes Sales by Product in 2024

12.4.6 BASF Specialty Enzymes Sales by Application in 2024

12.4.7 BASF Specialty Enzymes Sales by Geographic Area in 2024

12.4.8 BASF Specialty Enzymes SWOT Analysis

12.4.9 BASF Recent Developments

12.5 AB Enzymes

12.5.1 AB Enzymes Corporation Information

12.5.2 AB Enzymes Business Overview

12.5.3 AB Enzymes Specialty Enzymes Product Models, Descriptions and Specifications

12.5.4 AB Enzymes Specialty Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 AB Enzymes Specialty Enzymes Sales by Product in 2024

12.5.6 AB Enzymes Specialty Enzymes Sales by Application in 2024

12.5.7 AB Enzymes Specialty Enzymes Sales by Geographic Area in 2024

12.5.8 AB Enzymes Specialty Enzymes SWOT Analysis

12.5.9 AB Enzymes Recent Developments

12.6 CHR.Hansen

12.6.1 CHR.Hansen Corporation Information

12.6.2 CHR.Hansen Business Overview

12.6.3 CHR.Hansen Specialty Enzymes Product Models, Descriptions and Specifications

12.6.4 CHR.Hansen Specialty Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 CHR.Hansen Recent Developments

12.7 Soufflet Group

12.7.1 Soufflet Group Corporation Information

12.7.2 Soufflet Group Business Overview

12.7.3 Soufflet Group Specialty Enzymes Product Models, Descriptions and Specifications

12.7.4 Soufflet Group Specialty Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 Soufflet Group Recent Developments

12.8 Longda Bio-products

12.8.1 Longda Bio-products Corporation Information

12.8.2 Longda Bio-products Business Overview

12.8.3 Longda Bio-products Specialty Enzymes Product Models, Descriptions and Specifications

12.8.4 Longda Bio-products Specialty Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 Longda Bio-products Recent Developments

12.9 Biocatalysts

12.9.1 Biocatalysts Corporation Information

12.9.2 Biocatalysts Business Overview

12.9.3 Biocatalysts Specialty Enzymes Product Models, Descriptions and Specifications

12.9.4 Biocatalysts Specialty Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 Biocatalysts Recent Developments

12.10 ORBA

12.10.1 ORBA Corporation Information

12.10.2 ORBA Business Overview

12.10.3 ORBA Specialty Enzymes Product Models, Descriptions and Specifications

12.10.4 ORBA Specialty Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 ORBA Recent Developments

12.11 Biovet

12.11.1 Biovet Corporation Information

12.11.2 Biovet Business Overview

12.11.3 Biovet Specialty Enzymes Product Models, Descriptions and Specifications

12.11.4 Biovet Specialty Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.11.5 Biovet Recent Developments

muLu

13 Value Chain and Supply-Chain Analysis

13.1 Specialty Enzymes Industry Chain

13.2 Specialty Enzymes Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Specialty Enzymes Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Specialty Enzymes Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

muLu

14 Specialty Enzymes Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

muLu

15 Key Findings in the Global Specialty Enzymes Study

muLu

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Specialty Enzymes Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Specialty Enzymes Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Specialty Enzymes Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Specialty Enzymes Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Specialty Enzymes Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Specialty Enzymes Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K MT)
Table 7. Global Specialty Enzymes Sales by Region (2020-2025) & (K MT)
Table 8. Global Specialty Enzymes Sales by Region (2026-2031) & (K MT)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Specialty Enzymes Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K MT)
Table 11. Global Specialty Enzymes Production by Region (2020-2025) & (K MT)
Table 12. Global Specialty Enzymes Production by Region (2026-2031) & (K MT)
Table 13. Global Specialty Enzymes Sales by Manufacturers (2020-2025) & (K MT)
Table 14. Global Specialty Enzymes Sales Share by Manufacturers (2020-2025)
Table 15. Global Specialty Enzymes Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Specialty Enzymes Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Specialty Enzymes by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Enzymes as of 2024)
Table 19. Global Specialty Enzymes Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Specialty Enzymes Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Specialty Enzymes Manufacturing Base and Headquarters
Table 22. Global Specialty Enzymes Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Specialty Enzymes Sales by Type (2020-2025) & (K MT)
Table 26. Global Specialty Enzymes Sales by Type (2026-2031) & (K MT)
Table 27. Global Specialty Enzymes Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Specialty Enzymes Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Specialty Enzymes ASP by Type (2020-2031) & (USD/MT)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Specialty Enzymes Sales by Application (2020-2025) & (K MT)
Table 32. Global Specialty Enzymes Sales by Application (2026-2031) & (K MT)
Table 33. Specialty Enzymes High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Specialty Enzymes Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Specialty Enzymes Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Specialty Enzymes ASP by Application (2020-2031) & (USD/MT)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Specialty Enzymes Growth Accelerators and Market Barriers
Table 40. North America Specialty Enzymes Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Specialty Enzymes Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Specialty Enzymes Growth Accelerators and Market Barriers
Table 43. Europe Specialty Enzymes Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Specialty Enzymes Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Specialty Enzymes Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Specialty Enzymes Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Specialty Enzymes Growth Accelerators and Market Barriers
Table 48. Southeast Asia Specialty Enzymes Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Specialty Enzymes Investment Opportunities and Key Challenges
Table 50. Central and South America Specialty Enzymes Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Specialty Enzymes Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Specialty Enzymes Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Novozymes Corporation Information
Table 54. Novozymes Description and Major Businesses
Table 55. Novozymes Product Models, Descriptions and Specifications
Table 56. Novozymes Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Novozymes Sales Value Proportion by Product in 2024
Table 58. Novozymes Sales Value Proportion by Application in 2024
Table 59. Novozymes Sales Value Proportion by Geographic Area in 2024
Table 60. Novozymes Specialty Enzymes SWOT Analysis
Table 61. Novozymes Recent Developments
Table 62. Dupont Corporation Information
Table 63. Dupont Description and Major Businesses
Table 64. Dupont Product Models, Descriptions and Specifications
Table 65. Dupont Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 66. Dupont Sales Value Proportion by Product in 2024
Table 67. Dupont Sales Value Proportion by Application in 2024
Table 68. Dupont Sales Value Proportion by Geographic Area in 2024
Table 69. Dupont Specialty Enzymes SWOT Analysis
Table 70. Dupont Recent Developments
Table 71. DSM Corporation Information
Table 72. DSM Description and Major Businesses
Table 73. DSM Product Models, Descriptions and Specifications
Table 74. DSM Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. DSM Sales Value Proportion by Product in 2024
Table 76. DSM Sales Value Proportion by Application in 2024
Table 77. DSM Sales Value Proportion by Geographic Area in 2024
Table 78. DSM Specialty Enzymes SWOT Analysis
Table 79. DSM Recent Developments
Table 80. BASF Corporation Information
Table 81. BASF Description and Major Businesses
Table 82. BASF Product Models, Descriptions and Specifications
Table 83. BASF Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. BASF Sales Value Proportion by Product in 2024
Table 85. BASF Sales Value Proportion by Application in 2024
Table 86. BASF Sales Value Proportion by Geographic Area in 2024
Table 87. BASF Specialty Enzymes SWOT Analysis
Table 88. BASF Recent Developments
Table 89. AB Enzymes Corporation Information
Table 90. AB Enzymes Description and Major Businesses
Table 91. AB Enzymes Product Models, Descriptions and Specifications
Table 92. AB Enzymes Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. AB Enzymes Sales Value Proportion by Product in 2024
Table 94. AB Enzymes Sales Value Proportion by Application in 2024
Table 95. AB Enzymes Sales Value Proportion by Geographic Area in 2024
Table 96. AB Enzymes Specialty Enzymes SWOT Analysis
Table 97. AB Enzymes Recent Developments
Table 98. CHR.Hansen Corporation Information
Table 99. CHR.Hansen Description and Major Businesses
Table 100. CHR.Hansen Product Models, Descriptions and Specifications
Table 101. CHR.Hansen Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. CHR.Hansen Recent Developments
Table 103. Soufflet Group Corporation Information
Table 104. Soufflet Group Description and Major Businesses
Table 105. Soufflet Group Product Models, Descriptions and Specifications
Table 106. Soufflet Group Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Soufflet Group Recent Developments
Table 108. Longda Bio-products Corporation Information
Table 109. Longda Bio-products Description and Major Businesses
Table 110. Longda Bio-products Product Models, Descriptions and Specifications
Table 111. Longda Bio-products Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Longda Bio-products Recent Developments
Table 113. Biocatalysts Corporation Information
Table 114. Biocatalysts Description and Major Businesses
Table 115. Biocatalysts Product Models, Descriptions and Specifications
Table 116. Biocatalysts Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Biocatalysts Recent Developments
Table 118. ORBA Corporation Information
Table 119. ORBA Description and Major Businesses
Table 120. ORBA Product Models, Descriptions and Specifications
Table 121. ORBA Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. ORBA Recent Developments
Table 123. Biovet Corporation Information
Table 124. Biovet Description and Major Businesses
Table 125. Biovet Product Models, Descriptions and Specifications
Table 126. Biovet Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Biovet Recent Developments
Table 128. Key Raw Materials Distribution
Table 129. Raw Materials Key Suppliers
Table 130. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 131. Milestones in Production Technology Evolution
Table 132. Distributors List
Table 133. Market Trends and Market Evolution
Table 134. Market Drivers and Opportunities
Table 135. Market Challenges, Risks, and Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Specialty Enzymes Product Picture
Figure 2. Global Specialty Enzymes Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Protease Product Picture
Figure 4. Carbohydrases Product Picture
Figure 5. Polymerases and Nucleases Product Picture
Figure 6. Lipase Product Picture
Figure 7. Others Product Picture
Figure 8. Global Specialty Enzymes Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Pharmaceutical Applications
Figure 10. Biotechnology and R&D Application
Figure 11. Others
Figure 12. Specialty Enzymes Report Years Considered
Figure 13. Global Specialty Enzymes Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Specialty Enzymes Revenue (2020-2031) & (US$ Million)
Figure 15. Global Specialty Enzymes Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Specialty Enzymes Revenue Market Share by Region (2020-2031)
Figure 17. Global Specialty Enzymes Sales (2020-2031) & (K MT)
Figure 18. Global Specialty Enzymes Sales (CAGR) by Region (2020-2031) (K MT)
Figure 19. Global Specialty Enzymes Sales Market Share by Region (2020-2031)
Figure 20. Global Specialty Enzymes Capacity, Production and Utilization (2020-2031) & (K MT)
Figure 21. Global Specialty Enzymes Production Trend by Region (2020-2031) (K MT)
Figure 22. Global Specialty Enzymes Production Market Share by Region (2020-2031)
Figure 23. Production Capacity Enablers & Constraints
Figure 24. Specialty Enzymes Production Growth Rate in North America (2020-2031) & (K MT)
Figure 25. Specialty Enzymes Production Growth Rate in Europe (2020-2031) & (K MT)
Figure 26. Specialty Enzymes Production Growth Rate in China (2020-2031) & (K MT)
Figure 27. Specialty Enzymes Production Growth Rate in Japan (2020-2031) & (K MT)
Figure 28. Top 5 and Top 10 Manufacturers Specialty Enzymes Sales Volume Market Share in 2024
Figure 29. Global Specialty Enzymes Revenue Market Share Ranking (2024)
Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 31. Protease Revenue Market Share by Manufacturer in 2024
Figure 32. Carbohydrases Revenue Market Share by Manufacturer in 2024
Figure 33. Polymerases and Nucleases Revenue Market Share by Manufacturer in 2024
Figure 34. Lipase Revenue Market Share by Manufacturer in 2024
Figure 35. Others Revenue Market Share by Manufacturer in 2024
Figure 36. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 37. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 38. Global Specialty Enzymes Sales Market Share by Type (2020-2031)
Figure 39. Global Specialty Enzymes Revenue Market Share by Type (2020-2031)
Figure 40. Global Specialty Enzymes Sales Market Share by Application (2020-2031)
Figure 41. Global Specialty Enzymes Revenue Market Share by Application (2020-2031)
Figure 42. North America Specialty Enzymes Sales YoY (2020-2031) & (K MT)
Figure 43. North America Specialty Enzymes Revenue YoY (2020-2031) & (US$ Million)
Figure 44. North America Top 5 Manufacturers Specialty Enzymes Sales Revenue (US$ Million) in 2024
Figure 45. North America Specialty Enzymes Sales Volume (K MT) by Type (2020- 2031)
Figure 46. North America Specialty Enzymes Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 47. North America Specialty Enzymes Sales Volume (K MT) by Application (2020-2031)
Figure 48. North America Specialty Enzymes Sales Revenue (US$ Million) by Application (2020-2031)
Figure 49. US Specialty Enzymes Revenue (2020-2031) & (US$ Million)
Figure 50. Canada Specialty Enzymes Revenue (2020-2031) & (US$ Million)
Figure 51. Mexico Specialty Enzymes Revenue (2020-2031) & (US$ Million)
Figure 52. Europe Specialty Enzymes Sales YoY (2020-2031) & (K MT)
Figure 53. Europe Specialty Enzymes Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Europe Top 5 Manufacturers Specialty Enzymes Sales Revenue (US$ Million) in 2024
Figure 55. Europe Specialty Enzymes Sales Volume (K MT) by Type (2020-2031)
Figure 56. Europe Specialty Enzymes Sales Revenue (US$ Million) by Type (2020-2031)
Figure 57. Europe Specialty Enzymes Sales Volume (K MT) by Application (2020-2031)
Figure 58. Europe Specialty Enzymes Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Germany Specialty Enzymes Revenue (2020-2031) & (US$ Million)
Figure 60. France Specialty Enzymes Revenue (2020-2031) & (US$ Million)
Figure 61. U.K. Specialty Enzymes Revenue (2020-2031) & (US$ Million)
Figure 62. Italy Specialty Enzymes Revenue (2020-2031) & (US$ Million)
Figure 63. Russia Specialty Enzymes Revenue (2020-2031) & (US$ Million)
Figure 64. Asia-Pacific Specialty Enzymes Sales YoY (2020-2031) & (K MT)
Figure 65. Asia-Pacific Specialty Enzymes Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Asia-Pacific Top 8 Manufacturers Specialty Enzymes Sales Revenue (US$ Million) in 2024
Figure 67. Asia-Pacific Specialty Enzymes Sales Volume (K MT) by Type (2020- 2031)
Figure 68. Asia-Pacific Specialty Enzymes Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 69. Asia-Pacific Specialty Enzymes Sales Volume (K MT) by Application (2020-2031)
Figure 70. Asia-Pacific Specialty Enzymes Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Indonesia Specialty Enzymes Revenue (2020-2031) & (US$ Million)
Figure 72. Japan Specialty Enzymes Revenue (2020-2031) & (US$ Million)
Figure 73. South Korea Specialty Enzymes Revenue (2020-2031) & (US$ Million)
Figure 74. China Taiwan Specialty Enzymes Revenue (2020-2031) & (US$ Million)
Figure 75. India Specialty Enzymes Revenue (2020-2031) & (US$ Million)
Figure 76. Central and South America Specialty Enzymes Sales YoY (2020-2031) & (K MT)
Figure 77. Central and South America Specialty Enzymes Revenue YoY (2020-2031) & (US$ Million)
Figure 78. Central and South America Top 5 Manufacturers Specialty Enzymes Sales Revenue (US$ Million) in 2024
Figure 79. Central and South America Specialty Enzymes Sales Volume (K MT) by Type (2021-2031)
Figure 80. Central and South America Specialty Enzymes Sales Revenue (US$ Million) by Type (2020-2031)
Figure 81. Central and South America Specialty Enzymes Sales Volume (K MT) by Application (2020-2031)
Figure 82. Central and South America Specialty Enzymes Sales Revenue (US$ Million) by Application (2020-2031)
Figure 83. Brazil Specialty Enzymes Revenue (2020-2025) & (US$ Million)
Figure 84. Argentina Specialty Enzymes Revenue (2020-2025) & (US$ Million)
Figure 85. Middle East, and Africa Specialty Enzymes Sales YoY (2020-2031) & (K MT)
Figure 86. Middle East and Africa Specialty Enzymes Revenue YoY (2020-2031) & (US$ Million)
Figure 87. Middle East and Africa Top 5 Manufacturers Specialty Enzymes Sales Revenue (US$ Million) in 2024
Figure 88. Middle East and Africa Specialty Enzymes Sales Volume (K MT) by Type (2021-2031)
Figure 89. South America Specialty Enzymes Sales Revenue (US$ Million) by Type (2020-2031)
Figure 90. Middle East and Africa Specialty Enzymes Sales Volume (K MT) by Application (2020-2031)
Figure 91. Middle East and Africa Specialty Enzymes Sales Revenue (US$ Million) by Application (2020-2031)
Figure 92. GCC Countries Specialty Enzymes Revenue (2020-2025) & (US$ Million)
Figure 93. Turkey Specialty Enzymes Revenue (2020-2025) & (US$ Million)
Figure 94. Egypt Specialty Enzymes Revenue (2020-2025) & (US$ Million)
Figure 95. South Africa Specialty Enzymes Revenue (2020-2025) & (US$ Million)
Figure 96. Specialty Enzymes Industry Chain Mapping
Figure 97. Regional Specialty Enzymes Manufacturing Base Distribution (%)
Figure 98. Specialty Enzymes Production Process
Figure 99. Regional Specialty Enzymes Production Cost Structure
Figure 100. Channels of Distribution (Direct Vs Distribution)
Figure 101. Bottom-up and Top-down Approaches for This Report
Figure 102. Data Triangulation
Figure 103. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share?zhanKai
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 7.5% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What is the annual compound growth rate of the global Specialty Enzymes market size from 2025 to 2031?shouQi
Which companies rank high in the global Specialty Enzymes market?shouQi
What was the global market size of Specialty Enzymes in 2031?shouQi
What was the global market size of Specialty Enzymes in 2025?shouQi
den_biaoTiZhungShi

Related Reports

Global Specialty Enzymes Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-10-26

Pages: 167 Pages

Report ld: 5285507

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now